Detection of Circulating Antibodies to p16 Protein-Derived Peptides in Hepatocellular Carcinoma

Yangchun Xu, MM; Litong Gu, MM; Jiaxin Wang, MD; Zhenqi Wang, MD; Ping Zhang, MD, PhD; Xuan Zhang, MD, PhD

Disclosures

Lab Med. 2020;51(6):574-578. 

In This Article

Conclusion

The results of this study, which was designed to explore the clinical applicability of circulating anti-p16 IgG levels in HCC diagnosis, suggest that circulating IgG antibodies to p16 protein might be a useful biomarker for HCC prognosis assessment compared to early HCC diagnosis.

Comments

3090D553-9492-4563-8681-AD288FA52ACE

processing....